CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer

Preclinical data demonstrates leronlimab-mediated CCR5 inhibition enhances Temozolomide and radiation response in Glioblastoma Leronlimab ...

CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference

Leronlimab-mediated CCR5 blockade modulates T-Cell exhaustion pathways and PD-L1 Biology relevant to ICI response Durable Clinical Observations and Favorable Safety Profile Observed in Heavily ...
Nature

Chemokine Receptor 5 and Its Role in Cancer Progression and Metastasis

Chemokine Receptor 5 (CCR5) is a G-protein coupled receptor long recognised for its role in immune cell trafficking and as a co-receptor for HIV. However, increasing evidence over recent years has ...
Medscape

Role of CXCR4 in HIV Infection and its Potential as a Therapeutic Target

The chemokine receptors CCR5 and CXCR4 are the two major coreceptors for HIV entry. Numerous efforts have been made to develop a new class of anti-HIV agents that target these coreceptors as an ...
Yahoo Finance

CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab

VANCOUVER, Washington, March 05, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized ...
Medscape

Maraviroc: A Coreceptor CCR5 Antagonist for Management of HIV Infection

Am J Health Syst Pharm. 2009;66(8):715-726. Mechanism of action of maraviroc. Before fusion of the HIV viral envelope and host cell membrane can occur, an HIV glycoprotein complex consisting of ...
Healio

Q&A: HIV drug may be key to halting glioblastoma cell growth

Please provide your email address to receive an email when new articles are posted on . Brain cancers such as glioblastoma significantly affect quality of life and shorten the lifespan. The mechanism ...